What is the management for a 16-year-old with impaired renal function?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Impaired Renal Function in a 16-Year-Old

A 16-year-old with elevated creatinine and BUN requires prompt referral to a pediatric nephrologist for comprehensive evaluation and management, with initial treatment focusing on identifying the underlying cause while implementing renoprotective measures including ACE inhibitors or ARBs for hypertension and proteinuria. 1

Initial Assessment

Diagnostic Evaluation

  • Measure urine albumin-to-creatinine ratio to assess for proteinuria 1
  • Calculate estimated glomerular filtration rate (eGFR) 1
  • Screen for hypertension (defined as ≥95th percentile for age, sex, and height or ≥130/80 mmHg in adolescents ≥13 years) 1
  • Consider kidney biopsy if etiology is unclear 1, 2
  • Genetic testing if suspicion for hereditary kidney disease 1, 2

Common Causes to Consider

  • Primary glomerular disease (nephrotic syndrome)
  • Secondary causes (diabetes, hypertension, autoimmune disease)
  • Congenital/hereditary kidney disorders
  • Medication-induced nephrotoxicity
  • Post-infectious glomerulonephritis

Treatment Algorithm

1. Hypertension Management

  • If blood pressure is elevated (≥95th percentile or ≥130/80 mmHg):
    • Start with ACE inhibitor or ARB as first-line therapy 1
    • Target blood pressure <90th percentile or <130/80 mmHg 1
    • Important: Provide reproductive counseling for females due to teratogenic effects of ACE inhibitors/ARBs 1

2. Proteinuria Management

  • For mild-moderate proteinuria (30-299 mg/g creatinine):
    • ACE inhibitor or ARB recommended 1
  • For severe proteinuria (≥300 mg/g creatinine):
    • Higher doses of ACE inhibitor or ARB 1
    • Consider additional therapies based on underlying diagnosis

3. Nephrotic Syndrome Management

If steroid-sensitive nephrotic syndrome:

  • Initial treatment with oral prednisone 1
  • For frequently relapsing cases, consider steroid-sparing agents 1

If steroid-resistant nephrotic syndrome:

  • Calcineurin inhibitors (CNIs) are first-line therapy 2
  • Continue CNIs for minimum 6 months to assess response 2
  • Consider mycophenolate mofetil if CNIs fail 2

4. Supportive Care

  • Fluid management: Avoid excessive fluid restriction or overload 1
  • Dietary modifications:
    • Sodium restriction if edematous
    • Protein intake appropriate for age
    • Potassium restriction if hyperkalemic
  • Monitor for and treat electrolyte imbalances
  • Avoid nephrotoxic medications 3

Monitoring Parameters

  • Regular assessment of kidney function (creatinine, BUN, eGFR) 1
  • Urine albumin-to-creatinine ratio monitoring 1
  • Blood pressure monitoring
  • Growth and development monitoring
  • Medication levels for certain therapies (e.g., CNIs)

Indications for Nephrology Referral

Referral to nephrology is recommended in cases of:

  • Uncertainty of etiology
  • Worsening proteinuria
  • Decreasing eGFR
  • Resistant hypertension
  • Need for specialized therapies 1

Prognosis and Long-term Considerations

  • Risk stratification based on degree of renal impairment 4
  • Early intervention improves outcomes
  • Monitor for complications of chronic kidney disease:
    • Anemia
    • Metabolic bone disease
    • Growth impairment
    • Cardiovascular complications

Potential Pitfalls and Caveats

  • Avoid dehydration, which can worsen renal function 3
  • Use caution with contrast agents; consider prophylactic hydration if contrast studies are necessary 5
  • Adjust medication dosages based on renal function 6
  • Monitor for medication side effects, particularly with ACE inhibitors/ARBs
  • Consider reproductive counseling for female adolescents on ACE inhibitors/ARBs 1

Early diagnosis and treatment are crucial to prevent progression to end-stage renal disease and improve quality of life in adolescents with impaired renal function.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Steroid-Resistant Nephrotic Syndrome (SRNS) Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Iatrogenic renal disease.

Archives of internal medicine, 1991

Research

Renal impairment and outcomes in heart failure: systematic review and meta-analysis.

Journal of the American College of Cardiology, 2006

Research

Anticoagulant use in patients with chronic renal impairment.

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.